Anti-tumor vaccine
US5156841A · kind A · utility
16Cited by
2References
3Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 26, 1988 |
| Grant date | Oct 20, 1992 |
| Priority date | — |
| Expiry date | Aug 26, 2008 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K39/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An antitumor vaccine utilizing oncoproteins as immunogen is disclosed. The oncoprotein could be administered either as isolated, substantially pure product or expressed through a recombinant vaccinia virus containing either the complete coding sequence for the oncoprotein(s) or portions thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.